|
News Archive
2007
December 7, 2007
Acologix Presents Preclinical Data on Cartilage
Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
November 12, 2007
Acologix to Present at Bio-Europe 2007
November 1, 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
October 10, 2007
Acologix Gives Presentation at 2007 BIO Investor Forum
2006
September 6, 2006
Acologix Licenses Novel Technology for Treatment of Interstitial Cystitis from University of Maryland, Baltimore
July 24, 2006
Acologix Announces Results
of
AC-100 Initial Feasibility Study for Treatment of Periodontal Disease
June 29, 2006
Acologix’s AC-100 (Dentonin®) Phase II Data on Dentin Formation in Humans Presented at the Annual Meeting of the International Association for Dental Research
June 19, 2006
Acologix and Toray Announce Partnership
on AC-200 (Phosphatonin)
June 8, 2006
Acologix Presents Preclinical Data on Bone Formation and Maturation Stimulated by AC-100 at the European Orthopedic Research Society Meeting
May 11, 2006
Acologix Presents Preclinical Data
on AC-100’S Novel Mechanism of Action – Researcher Awarded
Young Investigator's Award
March 22, 2006
Acologix's AC-100 Stimulates Mature
Bone Formation in Preclinical Study
March 10, 2006
Acologix Phase II Study of AC-100
(Dentonin®) Meets Goal of Stimulating New Dentin Formation with
Favorable Safety Profile in Novel Dental Application
March 3, 2006
Acologix Strenghtens Management Team with Addition of CFO
March 1, 2006
Acologix AC-100 (Dentonin®) Phase II Data to be Presented in ‘Late Breaking News Session’ at American Association for Dental Research Annual Meeting
February 15, 2006
Biopharmaceutical Industry Leader
Joins Acologix, Inc. Board of Directors
February 14, 2006
Acologix, Inc. Series C Financing
Totals $30 Million With Second Closing
February 9, 2006
Acologix Announces Presentation
at
BIO CEO & Investor Conference 2006
2005
December 20, 2005
Acologix, Inc. Closes $25 Million
Series C Financing
November 14, 2005
Acologix Presents Preclinical Data
on Phosphatonin at the 38th Annual meeting of The American Society
of Nephrology
September 26, 2005
Acologix Presents Preclinical Data
Demonstrating Therapeutic Benefit of AC-100 in Bone and Dental Applications
at the 27th Annual Meeting of the American Society for Bone and
Mineral Research (ASBMR)
September 12, 2005
Sarbani Bhaduri, M.D., Joins Acologix
as Vice President, Medical Affairs
June 16, 2005
Acologix and Toray Partner on Phase
III Therapeutic for Dialysis Patients
May 25, 2005
Acologix, Inc. Launches Second Phase
II Clinical Study for AC-100 (Dentonin®)
May 16, 2005
Acologix, Inc. Appointed Patrick
Murphy as Vice President, CMC and Operations
May 4, 2005
Acologix, Inc. Launches First Phase
II Clinical Study for AC-100 (Dentonin®) in Dentistry
2004
December, 21 2004
Acologix Announces Relocation
November 19, 2004
Drug Development Program Further
Strengthened with Issuance of a New Patent
October 4, 2004
Acologix Presents In Vivo Results
on AC-100
August 2, 2004
Acologix Appointed Aki Watanabe
as its 7th Board of Directors
May 27, 2004
Dale A. Stringfellow, Ph.D. Joins
Acologix’s Board of Directors
May 3, 2004
Acologix Closes $40 Million Series
B Financing
March 22, 2004
Acologix Adds Business Development
Leader to its Board of Directors
2003
April 30, 2003
Acologix Completes Phase I Clinical
Trial of Lead Compound Dentonin®
2002
December 20, 2002
Acologix Initiates Clinical Trial
of Its Lead Compound for Osteoporosis
September 20, 2002
Recombinant Human-Phosphatonin Produced
by Acologix InstantlyReduced Serum Levels of Phosphate by a Single
Injection
August 19, 2002
Acologix, Inc. Expands Management
Team David M. Rosen, Ph.D. Appointed Vice President, R&D, Mineral
Metabolism Projects
April 30, 2002
Acologix: The Science of Remedies
2001
September 11, 2001
Big Bear Bio Consolidated its Operations
in Bay Area
Latest News
| 
